When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA's Overreach on Compounded Peptides Is BPC 157 Legal? Understanding Its Status and Implications The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York